The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
Abstract
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Sniderman AD, Furberg CD. Why guideline-making requires reform. JAMA 2009;301:429–431.SnidermanAD]]FurbergCDWhy guideline-making requires reform.JAMA2009301429-4312. Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831–841.TricociP]]AllenJM]]KramerJM&etal;Scientific evidence underlying the ACC/AHA clinical practice guidelines.JAMA2009301831-8413. Shaneyfelt TM, Centor RM. Reassessment of clinical practice guidelines: go gently into that good night. JAMA 2009;301:868–869.ShaneyfeltTM]]CentorRMReassessment of clinical practice guidelines: go gently into that good night.JAMA2009301868-8694. Ronn SD. In the lymelight: law and clinical practice guidelines. South Med J 2009;102:626–630.RonnSDIn the lymelight: law and clinical practice guidelines.South Med J2009102626-6305. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, Human Granulocytic Anaplasmosis, and Babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089–1134.WormserGP]]DattwylerRJ]]ShapiroED&etal;The clinical assessment, treatment, and prevention of Lyme disease, Human Granulocytic Anaplasmosis, and Babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.Clin Infect Dis2006431089-11346. Connecticut Attorney General's Office. Attorney General's investigation reveals flawed Lyme disease guideline process, IDSA agrees to reassess guidelines, install independent arbiter. Available at: http://www.ct.gov/ag/cwp/view.asp?a=2795&q=414284. Accessed May 1, 2008.7. Klein JO. Danger ahead: politics intrude in Infectious Diseases Society of America guideline for Lyme disease. Clin Infect Dis 2008;47:1197–1199.KleinJODanger ahead: politics intrude in Infectious Diseases Society of America guideline for Lyme disease.Clin Infect Dis2008471197-11998. Cameron D, Gaito A, Harris N, et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther 2004;2 (1 suppl):S1–S13.CameronD]]GaitoA]]HarrisN&etal;Evidence-based guidelines for the management of Lyme disease.Expert Rev Anti Infect Ther20042S1-S139. Johnson L, Stricker RB. Treatment of Lyme disease: a medicolegal assessment. Expert Rev Anti Infect Ther 2004;2:533–557.JohnsonL]]StrickerRBTreatment of Lyme disease: a medicolegal assessment.Expert Rev Anti Infect Ther20042533-55710. Stricker RB, Lautin A, Burrascano JJ. Lyme disease: the quest for magic bullets. Chemotherapy 2006;52:53–59.StrickerRB]]LautinA]]BurrascanoJJLyme disease: the quest for magic bullets.Chemotherapy20065253-5911. Stricker RB, Johnson L. Chronic lyme disease and the ‘Axis of Evil.' Future Microbiol 2008;3:621–624.StrickerRB]]JohnsonLChronic lyme disease and the ‘Axis of Evil.’Future Microbiol20083621-624
